Literature DB >> 181516

Effect of guanyl nucleotides on parathyroid hormone-responsive adenylate cyclase in chick kidney.

N H Hunt, T J Martin, V P Michelangeli, J A Eisman.   

Abstract

Both guanosine 5'-triphosphate (GTP) AND 5'-guanylylimidodiphosphate (Gpp(NH)p) activated adenylate cyclase (EC4.6.1.1) in chick kidney plasma membranes. Half-maximal stimulation occurred at 3-1 X 10(-6)M for both agents. The maximum increases in adenylate cyclase activity produced by GTP and Gpp(NH)p were respectively 130 and 720% over basal activity. At the end of a 12 min incubation period GTP concentration was 85% of that originally added in the presence of an ATP-regenerating system but less than 20% in its absence. GTP and guanosine 5'-diphosphate inhibited the activation of adenylate cyclase by Gpp(NH)p, suggesting that they all acted at a common site. Gpp(NH)p facilitated the stimulation of adenylate cyclase activity by bovine parathyroid hormone (BPTH) and by the synthetic amino terminal fragment BPTH (1-34), decreasing the concentrations required for half-maximal enzyme activation by a factor of approximately eight in both cases. This property was not shared by the native nucleotide GTP. Gpp(NH)p rendered active (at certain concentrations) a synthetic parathyroid hormone peptide fragment, BPTH (2-34), which was incapable of Activating adenylate cyclase in the absence of the nucleotide analogue. This suggested that the GTP analogue, in addition to a direct effect upon adenylate cyclase activity, was capable of influencing hormone interaction with the enzyme complex.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 181516

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  11 in total

1.  Diuretics and the renal adenylate cyclase system.

Authors:  J K Dawborn; S Macneil; T J Martin
Journal:  Br J Pharmacol       Date:  1977-12       Impact factor: 8.739

2.  Proceedings: Transuterine, transendocervical and transvaginal potential differences in conscious woman measured in situ.

Authors:  S L Duncan; R J Levin
Journal:  J Physiol       Date:  1976-07       Impact factor: 5.182

3.  The calcitonin receptor on T 47D breast cancer cells. Evidence for glycosylation.

Authors:  J M Moseley; D M Findlay; J J Gorman; V P Michelangeli; T J Martin
Journal:  Biochem J       Date:  1983-06-15       Impact factor: 3.857

4.  Stimulation of hormone-responsive adenylate cyclase activity by a factor present in the cell cytosol.

Authors:  S MacNeil; A Crawford; H Amirrasooli; S Johnson; A Pollock; C Ollis; S Tomlinson
Journal:  Biochem J       Date:  1980-05-15       Impact factor: 3.857

5.  Adenylate cyclase of human articular chondrocytes. Responsiveness to prostaglandins and other hormones.

Authors:  J P Houston; M K McGuire; J E Meats; N M Ebsworth; R G Russell; A Crawford; S Mac Neil
Journal:  Biochem J       Date:  1982-10-15       Impact factor: 3.857

6.  Calcitonin binding and degradation by two cultured human breast cancer cell lines (MCF 7 and T 47D).

Authors:  D M Findlay; V P Michelangeli; J M Moseley; T J Martin
Journal:  Biochem J       Date:  1981-05-15       Impact factor: 3.857

7.  Human placental calcitonin receptors.

Authors:  G C Nicholson; C S D'Santos; T Evans; J M Moseley; B E Kemp; V P Michelangeli; T J Martin
Journal:  Biochem J       Date:  1988-03-15       Impact factor: 3.857

8.  Comparison of bone and osteosarcoma adenylate cyclase. Partial purification of membranes and kinetic properties of enzyme.

Authors:  S B Rodan; J J Egan; E E Golub; G A Rodan
Journal:  Biochem J       Date:  1980-03-01       Impact factor: 3.857

9.  Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells: a single receptor stimulates intracellular accumulation of both cAMP and inositol trisphosphates and increases intracellular free calcium.

Authors:  A B Abou-Samra; H Jüppner; T Force; M W Freeman; X F Kong; E Schipani; P Urena; J Richards; J V Bonventre; J T Potts
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

10.  Development of craniofacial structures in transgenic mice with constitutively active PTH/PTHrP receptor.

Authors:  T W Tsutsui; M Riminucci; Kenn Holmbeck; P Bianco; P G Robey
Journal:  Bone       Date:  2007-10-16       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.